Form 4 holding
Chief Medical Officer
Centessa Pharmaceuticals plc
- Security class
- Ordinary Shares
- Shares / value
- 158,932
- Estimated value
- $1,265,099
- Report date
- 03 Oct 2022
- Price
- $7.96
- Ownership
- Direct
Javad Shahidi
Insider Reports History
- Reporting-owner location
- Cheshire, United Kingdom
- Latest reporting-owner signature
-
/s/ Gregory Weinhoff, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Javad Shahidi
Insider Reports Filed by Javad Shahidi
4/A
CNTA
Centessa Pharmaceuticals plc
- Report period
- 30 Sep 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 23 Nov 2022, 16:04
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
CNTA
Centessa Pharmaceuticals plc
- Report period
- 01 Jul 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 06 Jul 2022, 18:15
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
CNTA
Centessa Pharmaceuticals plc
- Report period
- 01 Apr 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 04 Apr 2022, 18:00
- Role
- Chief Medical Officer
- Next action
- Open filing details
3
CNTA
Centessa Pharmaceuticals plc
- Report period
- 07 Mar 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 15 Mar 2022, 17:30
- Role
- Chief Medical Officer
- Next action
- Open filing details